Cargando…

Development and validation of a Q-PCR based TCID(50) method for human herpesvirus 6

BACKGROUND: For titer assessment of human herpesvirus 6 (HHV-6), IFA targeting viral proteins or a TCID(50) method with ocular inspection for CPE can be used. These methods rely on the subjective decision of the assessor, obstructing the ability to obtain unanimous results. FINDINGS: We have develop...

Descripción completa

Detalles Bibliográficos
Autores principales: Gustafsson, Rasmus K L, Engdahl, Elin E, Fogdell-Hahn, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546908/
https://www.ncbi.nlm.nih.gov/pubmed/23249654
http://dx.doi.org/10.1186/1743-422X-9-311
_version_ 1782256133209063424
author Gustafsson, Rasmus K L
Engdahl, Elin E
Fogdell-Hahn, Anna
author_facet Gustafsson, Rasmus K L
Engdahl, Elin E
Fogdell-Hahn, Anna
author_sort Gustafsson, Rasmus K L
collection PubMed
description BACKGROUND: For titer assessment of human herpesvirus 6 (HHV-6), IFA targeting viral proteins or a TCID(50) method with ocular inspection for CPE can be used. These methods rely on the subjective decision of the assessor, obstructing the ability to obtain unanimous results. FINDINGS: We have developed and validated an alternative TCID(50) read-out approach where infection in the titration culture plate is assessed by viral DNA load change by quantitative PCR. A ten time increase in viral DNA load was determined as cut point for infection since that yielded a maximum correlation with viral protein expression (93%). The average intra-assay CV was 9% for quantitative PCR read-out of TCID(50) compared to 45% for ocular inspection read-out of TCID(50), 14% for IFA read-out of TCID(50), and 43% for an infectious units approach using IFA. The average inter-assay CV for quantitative PCR read-out of TCID(50) was 73%, compared to 66%, 25% and 77% for the ocular inspection read-out for TCID(50), IFA read-out of TCID(50) and infectious unit approaches respectively. CONCLUSIONS: The quantitative PCR based read-out of TCID(50) proved to be more robust and easier to interpret than traditional TCID(50) assessment approaches for HHV-6, and therefore it might be considered as an alternative method.
format Online
Article
Text
id pubmed-3546908
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35469082013-01-17 Development and validation of a Q-PCR based TCID(50) method for human herpesvirus 6 Gustafsson, Rasmus K L Engdahl, Elin E Fogdell-Hahn, Anna Virol J Short Report BACKGROUND: For titer assessment of human herpesvirus 6 (HHV-6), IFA targeting viral proteins or a TCID(50) method with ocular inspection for CPE can be used. These methods rely on the subjective decision of the assessor, obstructing the ability to obtain unanimous results. FINDINGS: We have developed and validated an alternative TCID(50) read-out approach where infection in the titration culture plate is assessed by viral DNA load change by quantitative PCR. A ten time increase in viral DNA load was determined as cut point for infection since that yielded a maximum correlation with viral protein expression (93%). The average intra-assay CV was 9% for quantitative PCR read-out of TCID(50) compared to 45% for ocular inspection read-out of TCID(50), 14% for IFA read-out of TCID(50), and 43% for an infectious units approach using IFA. The average inter-assay CV for quantitative PCR read-out of TCID(50) was 73%, compared to 66%, 25% and 77% for the ocular inspection read-out for TCID(50), IFA read-out of TCID(50) and infectious unit approaches respectively. CONCLUSIONS: The quantitative PCR based read-out of TCID(50) proved to be more robust and easier to interpret than traditional TCID(50) assessment approaches for HHV-6, and therefore it might be considered as an alternative method. BioMed Central 2012-12-18 /pmc/articles/PMC3546908/ /pubmed/23249654 http://dx.doi.org/10.1186/1743-422X-9-311 Text en Copyright ©2012 Gustafsson et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Report
Gustafsson, Rasmus K L
Engdahl, Elin E
Fogdell-Hahn, Anna
Development and validation of a Q-PCR based TCID(50) method for human herpesvirus 6
title Development and validation of a Q-PCR based TCID(50) method for human herpesvirus 6
title_full Development and validation of a Q-PCR based TCID(50) method for human herpesvirus 6
title_fullStr Development and validation of a Q-PCR based TCID(50) method for human herpesvirus 6
title_full_unstemmed Development and validation of a Q-PCR based TCID(50) method for human herpesvirus 6
title_short Development and validation of a Q-PCR based TCID(50) method for human herpesvirus 6
title_sort development and validation of a q-pcr based tcid(50) method for human herpesvirus 6
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546908/
https://www.ncbi.nlm.nih.gov/pubmed/23249654
http://dx.doi.org/10.1186/1743-422X-9-311
work_keys_str_mv AT gustafssonrasmuskl developmentandvalidationofaqpcrbasedtcid50methodforhumanherpesvirus6
AT engdahleline developmentandvalidationofaqpcrbasedtcid50methodforhumanherpesvirus6
AT fogdellhahnanna developmentandvalidationofaqpcrbasedtcid50methodforhumanherpesvirus6